(Total Views: 621)
Posted On: 08/04/2020 12:17:56 PM
Post# of 154002
Re: generactor #46979
I sold exact sciences “way back” in the spring(seems so long ago) and bought Cytodyn and Humanigen among others.
I sold my humanigen when I learned through DD and the help of Dr. Patterson and the uber posters here, that lenzilumab has a narrow potential application in Covid (may still be great in CAR-T side effects, but so will leronlimab).
Were I to diversify from Cytodyn, it would only be for a demonstrably effective antiviral (Biocryst galidesivir is on my list but not among my holdings)
IMO opinion leronlimab has already been proven effective. It is a present wrapped and waiting to be opened. We know what awaits from EINDs, Patterson’s analyses and continued thinly veiled proclamations, the safety data and NEWS scores.
Sorry for spouting, but if the window of opportunity to get Cytodyn cheap is closing.
I sold my humanigen when I learned through DD and the help of Dr. Patterson and the uber posters here, that lenzilumab has a narrow potential application in Covid (may still be great in CAR-T side effects, but so will leronlimab).
Were I to diversify from Cytodyn, it would only be for a demonstrably effective antiviral (Biocryst galidesivir is on my list but not among my holdings)
IMO opinion leronlimab has already been proven effective. It is a present wrapped and waiting to be opened. We know what awaits from EINDs, Patterson’s analyses and continued thinly veiled proclamations, the safety data and NEWS scores.
Sorry for spouting, but if the window of opportunity to get Cytodyn cheap is closing.
(4)
(0)
